These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22166568)

  • 1. Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis.
    Landeira G; Morise S; Fassio E; Ramonet M; Alvarez E; Caglio P; Longo C; Domínguez N
    Ann Hepatol; 2012; 11(1):100-6. PubMed ID: 22166568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
    Feld JJ; Dinh H; Arenovich T; Marcus VA; Wanless IR; Heathcote EJ
    Hepatology; 2005 Jul; 42(1):53-62. PubMed ID: 15954109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
    De Luca-Johnson J; Wangensteen KJ; Hanson J; Krawitt E; Wilcox R
    Dig Dis Sci; 2016 Sep; 61(9):2710-20. PubMed ID: 27262844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
    Ngu JH; Gearry RB; Frampton CM; Stedman CA
    Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study).
    Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Ohta H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Komori A; Ito M; Yatsuhashi H; Nakamura M; Ishibashi H;
    Liver Int; 2012 May; 32(5):837-44. PubMed ID: 22221966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of patients with autoimmune hepatitis induced cirrhosis after immunosuppressive treatment.
    Hatoum S; Rockey DC
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):742-749. PubMed ID: 38555597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of poor response to therapy in Autoimmune Hepatitis.
    Muratori P; Lalanne C; Bianchi G; Lenzi M; Muratori L
    Dig Liver Dis; 2016 Sep; 48(9):1078-81. PubMed ID: 27378707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.
    Abdel-Razik A; Mousa N; Zakaria S; Elhelaly R; Elzehery R; Zalata K; Awad M; Eldeeb AA; Abdelsalam M
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1373-1379. PubMed ID: 29035910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study.
    Muratori P; Carbone M; Stangos G; Perini L; Lalanne C; Ronca V; Cazzagon N; Bianchi G; Lenzi M; Floreani A; Invernizzi P; Muratori L
    Dig Liver Dis; 2018 Jul; 50(7):698-702. PubMed ID: 29567415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
    Mohamadnejad M; Malekzadeh R; Nasseri-Moghaddam S; Hagh-Azali S; Rakhshani N; Tavangar SM; Sedaghat M; Alimohamadi SM
    Dig Dis Sci; 2005 Mar; 50(3):547-51. PubMed ID: 15810640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversibility of hepatic fibrosis in autoimmune hepatitis.
    Dufour JF; DeLellis R; Kaplan MM
    Ann Intern Med; 1997 Dec; 127(11):981-5. PubMed ID: 9412303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study.
    Díaz-Ramírez GS; Marín-Zuluaga JI; Donado-Gómez JH; Muñoz-Maya O; Santos-Sánchez Ó; Restrepo-Gutiérrez JC
    Gastroenterol Hepatol; 2018 Feb; 41(2):87-96. PubMed ID: 29126693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis.
    Puustinen L; Boyd S; Mustonen H; Arkkila P; Arola J; Färkkilä M
    Scand J Gastroenterol; 2017 Mar; 52(3):321-327. PubMed ID: 27846740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
    Baven-Pronk MAMC; Biewenga M; van Silfhout JJ; van den Berg AP; van Buuren HR; Verwer BJ; van Nieuwkerk CMJ; Bouma G; van Hoek B
    Clin Transl Gastroenterol; 2018 Jul; 9(6):165. PubMed ID: 29961755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hepatitis in African Americans: presenting features and response to therapy.
    Lim KN; Casanova RL; Boyer TD; Bruno CJ
    Am J Gastroenterol; 2001 Dec; 96(12):3390-4. PubMed ID: 11774954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis.
    Ferreira AR; Roquete ML; Toppa NH; de Castro LP; Fagundes ED; Penna FJ
    J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):65-70. PubMed ID: 18162836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.